New USDA Policy enables more U.S. research and vaccine development for foot and mouth disease (FMD), but biosecurity precautions and approval processes will take several years, says UDSA Chief Veterinarian Jack Shere.
Elanco Animal Health Incorporated has closed the acquisition of Bayer Animal Health. The $6.89-billion transaction brings over 166 years of legacy between the companies, said Jeff Simmons, president and CEO of Elanco.
As access to information continues to evolve, so do consumer perceptions of animal agriculture. Today, industry leaders are seeing increased questions from consumers regarding antimicrobial resistance in livestock.